Sihuan Pharmaceutical Holdings Group Ltd. (FRA:TEL1)
Germany flag Germany · Delayed Price · Currency is EUR
0.1420
+0.0050 (3.65%)
At close: Jan 23, 2026

FRA:TEL1 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
3,2573,5223,7793,8295,6824,604
Trading Asset Securities
341.71110.58589.02962.99109.3332.68
Cash & Short-Term Investments
3,5993,6334,3684,7925,7924,937
Cash Growth
-26.02%-16.82%-8.85%-17.26%17.32%-6.24%
Accounts Receivable
736.29593.93397.82522.25779.07389.82
Other Receivables
327.02303.21262.32342.67100.36317.66
Receivables
1,3731,3051,045977.611,094820.92
Inventory
472.25417557.32606.7715.3495.89
Other Current Assets
374.24362.32233.61174.23140.09150.62
Total Current Assets
5,8185,7186,2046,5507,7416,404
Property, Plant & Equipment
2,5762,6352,8422,9984,0933,841
Long-Term Investments
843.48818.041,004907.34972.531,267
Goodwill
1.851.851.851.8514.1712.31
Other Intangible Assets
899.05598.76655.52594.1445.8310.92
Long-Term Deferred Tax Assets
30.7632.1331.7796.77303.46269.45
Long-Term Deferred Charges
-242.97120.4432.36164.3194.7
Other Long-Term Assets
452.48362.32359.63393.46393.84400.82
Total Assets
10,62210,53211,53512,14114,49613,044
Accounts Payable
284.49241.93215.15205.78118.91106.2
Accrued Expenses
409.34490.06504.92700.081,077986.09
Short-Term Debt
15.7531.245.4625.830283.29
Current Portion of Long-Term Debt
181.56137.04269.68315.17170108.64
Current Portion of Leases
9.814.0624.521.35.191.44
Current Income Taxes Payable
68.5763.9744.2167.86111.2522.45
Current Unearned Revenue
106.54110.02143.05175.92214.11197.11
Other Current Liabilities
2,2512,2222,9001,021775.11737.87
Total Current Liabilities
3,3273,3104,1072,5332,5022,443
Long-Term Debt
768.76746.29905.03848.67844.75359.17
Long-Term Leases
51.2245.3851.9879.9431.462.51
Long-Term Unearned Revenue
298.08313.31163.28135.8182.3464.74
Long-Term Deferred Tax Liabilities
4.385.2670.3299.04222.39225.69
Other Long-Term Liabilities
1,2311,1621,1012,8041,663-
Total Liabilities
5,6815,5826,3986,5015,3463,095
Common Stock
77.0677.0677.0677.0677.0678.19
Additional Paid-In Capital
3,8823,8823,8823,8823,8824,085
Retained Earnings
599.21941.21,3361,6914,9224,628
Treasury Stock
-132.45-54.11-33.81---
Comprehensive Income & Other
-41.21-474.2-829.01-913.86-597.15398.83
Total Common Equity
4,3854,3724,4324,7378,2849,190
Minority Interest
556.13577.05704.89902.83865.92758.38
Shareholders' Equity
4,9414,9495,1375,6409,1509,949
Total Liabilities & Equity
10,62210,53211,53512,14114,49613,044
Total Debt
1,027974.011,2571,2911,081755.05
Net Cash (Debt)
2,5722,6593,1113,5014,7104,182
Net Cash Growth
-31.23%-14.53%-11.14%-25.67%12.64%-20.30%
Net Cash Per Share
0.280.290.330.380.500.44
Filing Date Shares Outstanding
9,1289,2449,2829,3309,3309,466
Total Common Shares Outstanding
9,1289,2449,2829,3309,3309,466
Working Capital
2,4912,4072,0974,0175,2403,961
Book Value Per Share
0.480.470.480.510.890.97
Tangible Book Value
3,4843,7723,7754,1417,8248,867
Tangible Book Value Per Share
0.380.410.410.440.840.94
Buildings
-3,5263,5393,5962,9562,763
Machinery
-1,6351,5721,5051,2881,147
Construction In Progress
-205.93295.53346.87819.92680.28
Source: S&P Global Market Intelligence. Standard template. Financial Sources.